Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Abbvie Therapeutics India Private Limited, is an unlisted private company incorporated on 04 July, 1994. It is classified as a private limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 10.00 cr and the total paid-up capital is INR 8.00 cr.
Abbvie Therapeutics India's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 8.84% over the previous year. At the same time, it's book networth has decreased by 33.1%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
7.52%
8.84%
7.63%
-33.1%
-6.14%
0.57
0.45
-0.06
47.71
45.67
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(14)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Ajay Gopikisan Piramal | 00028116 | 9 years |
| Director | Swati Ajay Piramal | 00067125 | 23 years |
| Managing Director | Suresh Pattathil | 02748206 | 4 years |
| Additional Director | Vidhan Kedia | 06718606 | 2 years |
| Director | Vivek Valsaraj | 06970246 | 3 years |
| Director | Kesavan Gopinath | 10307250 | 1 years |
| Director | Hong Liu Shi | 10424175 | 1 years |
| CS | Perumal Chinnaiah | <HIDDEN> | 3 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| GOPIKISAN PIRAMAL PRIVATE LIMITED |
Amalgamated
|
5.0 L | 2 | Maharashtra |
| PIRAMAL FINANCE LIMITED |
Amalgamated
|
3,735.5 Cr | 2 | Maharashtra |
| B M K LABORATORIES PRIVATE LIMITED |
Amalgamated
|
3.0 L | 1 | Maharashtra |
| PIRAMAL CAPITAL LIMITED |
Amalgamated
|
2.0 Cr | 1 | Maharashtra |
| PHL CAPITAL PRIVATE LIMITED |
Amalgamated
|
2,270.7 Cr | 1 | Maharashtra |
| KOJAM FININVEST LIMITED |
Amalgamated
|
10.0 Cr | 1 | Gujarat |
| PIRAMAL MANAGEMENT SERVICES PVT LTD |
Amalgamated
|
1.0 L | 2 | Maharashtra |
| PIRAMAL CAPITAL PRIVATE LIMITED |
Amalgamated
|
1.0 L | 2 | Maharashtra |
| PEL MANAGEMENT SERVICES PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| NICHOLAS PIRAMAL CONSUMER PRODUCTS PRIVA TE LIMITED |
Amalgamated
|
5.0 Cr | 1 | Maharashtra |
| PHL HOLDINGS PRIVATE LIMITED |
Amalgamated
|
1.6 Cr | 2 | Maharashtra |
| PGL HOLDINGS PRIVATE LIMITED |
Amalgamated
|
36.5 L | 2 | Maharashtra |
| PEL HOLDINGS PRIVATE LIMITED |
Amalgamated
|
23.8 L | 2 | Maharashtra |
| CAVAAL FININVEST PRIVATE LIMITED |
Amalgamated
|
1.0 Cr | 2 | Maharashtra |
| NUTAN NIRMATA FOUNDATION |
Active
|
10,000.0 | 1 | Gujarat |
| PRL REALTORS LLP |
Active
|
1.0 L | 2 | Maharashtra |
| PRL PROPERTIES LLP |
Active
|
1.0 L | 2 | Maharashtra |
| PIRAMAL FUND MANAGEMENT PRIVATE LIMITED |
Active
|
1.3 Cr | 1 | Maharashtra |
| PRATHAM EDUCATION FOUNDATION |
Active
|
0.0 | 1 | Maharashtra |
| KAIVALYA EDUCATION FOUNDATION |
Active
|
0.0 | 1 | Maharashtra |
| PIRAMAL FOUNDATION |
Active
|
0.0 | 1 | Maharashtra |
| PIRAMAL ENTERPRISES LIMITED |
Active
|
45.1 Cr | 2 | Maharashtra |
| PIRAMAL CAPITAL & HOUSING FINANCE LIMITED |
Amalgamated
|
19,283.7 Cr | 2 | Maharashtra |
| TAKING INDIA FORWARD FOUNDATION |
Active
|
1.0 L | 1 | Maharashtra |
| PIRAMAL CAPITAL & HOUSING FINANCE LIMITED |
Active
|
23,364.7 Cr | 2 | Maharashtra |
| TATA SONS PRIVATE LIMITED |
Active
|
42.4 Cr | 1 | Maharashtra |
| PIRAMAL GLASS PRIVATE LIMITED |
Active
|
79.7 Cr | 2 | Maharashtra |
| NPIL DR.PHADKE PATHOLOGY LABORATORY AND INFERTILITY CENTRE PVT LTD |
Amalgamated
|
30.0 L | 1 | Maharashtra |
| PHL FININVEST PRIVATE LIMITED |
Amalgamated
|
628.7 Cr | 1 | Maharashtra |
| ORGANISATION OF PHARMACEUTICAL PRODUCERS OF INDIA |
Active
|
0.0 | 1 | Maharashtra |
| ABBVIE HEALTHCARE INDIA PRIVATE LIMITED |
Active
|
2.1 Cr | 4 | Karnataka |
| INDO RAMA RENEWABLES VASPETH LLP |
Strike Off
|
1.0 L | 1 | Haryana |
| PIRAMAL PHARMACEUTICAL DEVELOPMENT SERVI CES PRIVATE LIMITED |
Amalgamated
|
150.1 Cr | 1 | Maharashtra |
| PIRAMAL PHARMA LIMITED |
Active
|
1,322.9 Cr | 1 | Maharashtra |
| CONVERGENCE CHEMICALS PRIVATE LIMITED |
Amalgamated
|
70.0 Cr | 1 | Maharashtra |
The incorporation date of ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED is 04 July, 1994
The authorized share capital of ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED is INR ₹ 10.0 Cr.
The paid-up capital of ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED is INR ₹ 8.0 Cr.
The registered address of ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED is PRESTIGE OBELISK LEVEL 6 AND LEVEL 7 KASTURBA ROAD NA BANGALORE Bangalore Karnataka - 560001
The CIN number of ABBVIE THERAPEUTICS INDIA PRIVATE LIMITED is U33201KA1994PTC023162.
Expand
Delete
Collapse
See
details
